nucleosid
analogu
nucleobas
synthes
evalu
antisarscov
activ
plaqu
reduct
yield
reduct
assay
order
develop
novel
antisarscov
agent
among
analogu
two
compound
name
exhibit
promis
antisarscov
activ
compar
mizoribin
ribavirin
known
antisarscov
agent
moreov
observ
sever
sar
trend
antivir
effect
moieti
unprotect
hydroxyl
group
benzoyl
hydroxyl
group
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
centuri
pose
global
threat
public
health
mainli
lead
fatal
infect
influenzalik
symptom
high
fever
dri
cough
pneumonia
dyspnoea
diseas
appear
guandong
provinc
southern
china
late
subsequ
spread
countri
earli
affect
approxim
person
overal
mortal
rate
sar
amount
approxim
follow
identif
caus
pathogena
new
coronaviru
cov
name
sarscovin
sever
compound
report
exhibit
antivir
activ
sarscov
howev
thu
far
effect
treatment
develop
previou
studi
sever
nucleosid
deriv
nucleobas
show
potent
antivir
activ
type
virus
presum
moieti
could
play
import
role
antivir
activ
fact
sever
analogu
known
inhibit
bacteri
rna
polymeras
therefor
expect
nucleosid
analogu
would
efficaci
sarscov
thu
sever
nucleosid
analogu
name
could
readili
prepar
commerci
avail
design
antisarscov
agent
fig
report
keyword
sarscov
nucleosid
antivir
correspond
author
email
maruyama
kphbunriuacjp
ribos
deriv
r
oh
r
oh
r
oh
x
cl
x
h
r
obz
r
oh
r
oh
x
cl
x
h
r
oh
r
oh
r
oh
x
ome
x
h
r
oh
r
oh
r
oh
x
sme
x
h
r
oh
r
oh
r
oh
x
cl
x
nh
compound
purchas
chemic
compani
prepar
accord
previou
literatur
synthes
deoxi
ribonucleosid
deriv
illustr
scheme
regioselect
protect
diol
moieti
yield
acetonid
subsequ
benzoyl
afford
yield
two
step
cleavag
acetonid
group
produc
desir
product
yield
acetyl
hydroxyl
group
deoxyadenosin
afford
transform
yield
two
step
deprotect
acetyl
group
accomplish
icewat
temperatur
avoid
decomposit
moieti
therebi
produc
desir
product
yield
synthes
acycl
analogu
carbocycl
oxetanocin
analogu
outlin
scheme
mitsunobu
reaction
known
alcohol
follow
remov
acetonid
group
result
desir
diol
yield
two
step
subsequ
monobenzoyl
carri
via
hydrolysi
correspond
orthobenzo
afford
desir
benzoat
yield
triol
prepar
describ
previou
literatur
convert
bissilyl
ether
compound
subject
mitsunobu
reaction
yield
deriv
final
cleavag
tb
group
produc
desir
yield
could
directli
convert
benzoat
instabl
moieti
basic
condit
antivir
effect
prepar
nucleosid
analogu
evalu
plaqu
reduct
assay
yield
reduct
assay
sarscov
strain
vero
cell
describ
previou
report
antisarscov
activ
determin
plaqu
reduct
assay
shown
figur
tabl
compound
show
potent
activ
ic
lm
lm
respect
compound
show
weak
activ
ic
lm
analogu
show
signific
activ
ic
lm
notabl
inhibitori
activ
compound
sarscov
compar
mizoribin
ribavirin
report
potenti
antisarscov
agent
group
although
antivir
indic
smaller
mizoribin
ribavirin
figur
illustr
antisarscov
activ
determin
yield
reduct
assay
inhibitori
effect
greatest
among
three
compound
viru
yield
concentr
approxim
lm
decreas
onehundredth
less
control
fig
left
import
note
inhibitori
effect
superior
mizoribin
ribavirin
sinc
approxim
lm
mizoribin
lm
ribavirin
requir
decreas
viru
yield
onetenth
control
case
compound
approxim
lm
compound
requir
reduc
viru
yield
onehundredth
control
fig
middl
right
result
reveal
sever
structureact
relationship
sar
trend
chlorin
atom
purin
base
consid
import
antisarscov
activ
compound
vs
howev
introduct
amino
group
correspond
guanin
deriv
unfavour
antivir
activ
compound
although
reason
trend
unclear
possibl
due
electrophil
natur
moieti
form
coval
bond
target
enzym
induc
effect
irrevers
inhibit
substitut
weak
leav
group
eg
ome
compound
sme
compound
chlorin
atom
led
diminut
antivir
activ
also
support
possibl
case
ribofuranosyl
structur
unprotect
hydroxyl
group
import
antivir
effect
compound
vs
would
indic
follow
intracellular
phosphoryl
hydroxyl
group
correspond
triphosph
compound
exhibit
antivir
activ
manner
common
nucleosid
antivir
type
sugar
moieti
also
influenc
antisarscov
activ
exampl
deoxyand
deoxyribonucleosid
deriv
show
weak
antivir
activ
compar
ribonucleosid
deriv
convers
acycl
backbon
imit
antivir
agent
penciclovir
ie
hydroxymethyl
butyl
guanin
also
decreas
activ
compound
vs
interestingli
carbocycl
oxetanocin
analogu
whose
hydroxyl
group
protect
benzoyl
exhibit
potenti
activ
compar
unprotect
exhibit
almost
activ
trend
seem
differ
common
nucleosid
antivir
includ
compound
could
indic
compound
act
sarscov
anoth
pathway
involv
intracellular
phosphoryl
conclus
synthes
sever
nucleosid
analogu
nucleobas
among
analogu
two
compound
name
found
efficaci
sarscov
show
antivir
activ
compar
mizoribin
ribavirin
studi
reveal
sever
curiou
sar
trend
antivir
effect
moieti
compound
unprotect
hydroxyl
group
compound
protect
benzoyl
hydroxyl
group
compound
although
issu
reduct
cytotox
remain
resolv
hope
result
present
studi
contribut
develop
antivir
agent
sarscov
studi
focu
optimis
synthes
compound
biolog
evalu
report
due
cours
figur
inhibitori
effect
nucleosid
analogu
yield
reduct
assay
experi
perform
least
three
time
independ
sarscov
strain
vero
cell
experi
perform
least
three
time
independ
sarscov
strain
vero
cell
b
averag
inhibitori
concentr
concentr
requir
reduc
viru
plaqu
format
c
averag
cytotox
concentr
cc
concentr
requir
reduc
cell
growth
cc
measur
use
cytotox
assay
kit
antivir
index
defin
toxic
dose
divid
inhibitori
dose
e
extract
obtain
previou
studi
